Literature DB >> 15302861

Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].

Ineke P Stolze1, Ya-Min Tian, Rebecca J Appelhoff, Helen Turley, Charles C Wykoff, Jonathan M Gleadle, Peter J Ratcliffe.   

Abstract

Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that directs a broad range of cellular responses to hypoxia. Recent studies have defined a set of 2-oxoglutarate and Fe(II)-dependent dioxygenases that modify HIF-alpha subunits by prolyl and asparaginyl hydroxylation. These processes potentially provide a dual system of control, down-regulating both HIF-alpha stability and transcriptional activity. Although genetic analyses in both primitive organisms and mammalian cells have demonstrated a critical role for the prolyl hydroxylase pathway in the regulation of HIF, analogous studies have not been performed on the HIF asparaginyl hydroxylase pathway, and its role in directing the expression of endogenous HIF transcriptional targets has not yet been clearly defined. Here we demonstrate, using small interfering RNA-mediated FIH suppression and controlled overexpression by a doxycycline-inducible system, that alterations in FIH expression in both directions have reciprocal effects on the expression of a range of HIF target genes. These effects were observed in normoxic and severely hypoxic cells but not anoxic cells. Evidence for FIH activity in severely hypoxic cells contrasted with results for the prolyl hydroxylase PHD2, suggesting that these enzymes display different oxygen dependence in vivo, with PHD2 requiring higher levels of oxygen for biological activity. Our results demonstrate an important physiological role for FIH in regulating HIF-dependent target genes over a wide range of oxygen tensions and indicate that inhibition of FIH has the potential to augment HIF target gene expression even in severe hypoxia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302861     DOI: 10.1074/jbc.M406713200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  Prevention of apoptosis by the interaction between FIH1 and Bax.

Authors:  Biao Yan; Men Kong; Yi-han Chen
Journal:  Mol Cell Biochem       Date:  2010-11-11       Impact factor: 3.396

3.  The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.

Authors:  Qin Yan; Steven Bartz; Mao Mao; Lianjie Li; William G Kaelin
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

4.  MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.

Authors:  Han Peng; Robert B Hamanaka; Julia Katsnelson; Liang-Liang Hao; Wending Yang; Navdeep S Chandel; Robert M Lavker
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

5.  The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.

Authors:  Sophie Beyer; Malene Maag Kristensen; Kim Steen Jensen; Jens Vilstrup Johansen; Peter Staller
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

Review 6.  Regulation of angiogenesis by oxygen sensing mechanisms.

Authors:  Guo-Hua Fong
Journal:  J Mol Med (Berl)       Date:  2009-03-14       Impact factor: 4.599

7.  Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Authors:  Matthew E Cockman; James D Webb; Holger B Kramer; Benedikt M Kessler; Peter J Ratcliffe
Journal:  Mol Cell Proteomics       Date:  2008-10-20       Impact factor: 5.911

8.  A dialogue between the hypoxia-inducible factor and the tumor microenvironment.

Authors:  Frédéric Dayan; Nathalie M Mazure; M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Cancer Microenviron       Date:  2008-03-19

9.  BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.

Authors:  M Yan; M Rayoo; E A Takano; H Thorne; S B Fox
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

10.  mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft.

Authors:  Darren Magda; Philip Lecane; Julia Prescott; Patricia Thiemann; Xuan Ma; Patricia K Dranchak; Donna M Toleno; Krishna Ramaswamy; Kimberly D Siegmund; Joseph G Hacia
Journal:  BMC Genomics       Date:  2008-11-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.